Cell BiologybioRxiv
Three-dimensional drug screen identifies HDAC inhibitors as therapeutic agents in mTORC1-driven lymphangioleiomyomatosis
A. Pietrobon, J. Yockell-Lelievre, N. Melong…·W. L. Stanford
A 3D drug screen identified HDAC inhibitors as effective against mTORC1-driven lymphangioleiomyomatosis by reducing invasion and selectively killing TSC2-/- cells.